CA1256374A - Bromocriptine compositions - Google Patents

Bromocriptine compositions

Info

Publication number
CA1256374A
CA1256374A CA000475119A CA475119A CA1256374A CA 1256374 A CA1256374 A CA 1256374A CA 000475119 A CA000475119 A CA 000475119A CA 475119 A CA475119 A CA 475119A CA 1256374 A CA1256374 A CA 1256374A
Authority
CA
Canada
Prior art keywords
bromocriptine
formulation according
fatty material
capsule
weight ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000475119A
Other languages
English (en)
French (fr)
Inventor
Othmar Zuger
Norman Mazer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1256374A publication Critical patent/CA1256374A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000475119A 1984-02-29 1985-02-26 Bromocriptine compositions Expired CA1256374A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions
GB8405227 1984-02-29

Publications (1)

Publication Number Publication Date
CA1256374A true CA1256374A (en) 1989-06-27

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000475119A Expired CA1256374A (en) 1984-02-29 1985-02-26 Bromocriptine compositions

Country Status (26)

Country Link
JP (1) JPS60202812A (es)
AT (1) AT387716B (es)
AU (2) AU586621B2 (es)
BE (1) BE901810A (es)
CA (1) CA1256374A (es)
CH (2) CH666406A5 (es)
DE (1) DE3505743C2 (es)
DK (1) DK175016B1 (es)
ES (1) ES8705223A1 (es)
FR (1) FR2560047B1 (es)
GB (1) GB8405227D0 (es)
GR (1) GR850506B (es)
HK (1) HK85490A (es)
HU (1) HU196121B (es)
IE (1) IE58235B1 (es)
IL (1) IL74459A (es)
IT (1) IT1199948B (es)
LU (1) LU85791A1 (es)
MX (1) MX9203626A (es)
NL (1) NL194231C (es)
NZ (1) NZ211247A (es)
PH (1) PH23266A (es)
PT (1) PT80015B (es)
SE (2) SE8500961L (es)
SG (1) SG69390G (es)
ZA (1) ZA851546B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
CA2156408C (en) * 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (es) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
ES540807A0 (es) 1987-05-01
NL194231B (nl) 2001-06-01
FR2560047B1 (fr) 1988-01-15
HK85490A (en) 1990-10-25
SE8500961D0 (sv) 1985-02-27
MX9203626A (es) 1992-09-01
DE3505743A1 (de) 1985-08-29
JPS60202812A (ja) 1985-10-14
HU196121B (en) 1988-10-28
PT80015B (pt) 1987-09-18
IT8547703A0 (it) 1985-02-20
FR2560047A1 (fr) 1985-08-30
DK175016B1 (da) 2004-04-26
SE462259B (sv) 1990-05-28
DK86785D0 (da) 1985-02-26
ATA58085A (de) 1988-08-15
BE901810A (fr) 1985-08-26
CH667009A5 (de) 1988-09-15
IE58235B1 (en) 1993-08-11
JPH0448776B2 (es) 1992-08-07
IE850495L (en) 1985-08-29
AU3913685A (en) 1985-09-05
NZ211247A (en) 1989-02-24
DK86785A (da) 1985-08-30
IT8547703A1 (it) 1986-08-20
LU85791A1 (fr) 1985-12-11
PT80015A (pt) 1986-02-10
AU586621B2 (en) 1989-07-20
NL194231C (nl) 2001-10-02
AU3500689A (en) 1989-09-14
GR850506B (es) 1985-06-28
IL74459A0 (en) 1985-05-31
HUT38254A (en) 1986-05-28
GB8405227D0 (en) 1984-04-04
ZA851546B (en) 1986-10-29
IT1199948B (it) 1989-01-05
SE8500961L (sv) 1985-08-30
IL74459A (en) 1988-12-30
AU618599B2 (en) 1992-01-02
NL8500417A (nl) 1985-09-16
DE3505743C2 (de) 1995-02-16
AT387716B (de) 1989-03-10
SG69390G (en) 1990-10-26
PH23266A (en) 1989-06-23
ES8705223A1 (es) 1987-05-01
CH666406A5 (de) 1988-07-29

Similar Documents

Publication Publication Date Title
AU718052B2 (en) Intestinal absorption of nicotine to treat nicotine responsive conditions
EP0531611B1 (en) Controlled release matrix for pharmaceuticals
CA2406373C (en) Controlled release paracetamol composition
GB2154874A (en) Bromocriptine compositions
AU2001260212A1 (en) Composition
US5399360A (en) Pharmaceutical compositions
CZ287558B6 (en) Pharmaceutical preparation
AU597570B2 (en) Pharmaceutical 9,10-dehydrogenated ergot alkaloid containing compositions
CA1256374A (en) Bromocriptine compositions
US5069911A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
PT85880B (pt) Processo para a preparacao de composicoes farmaceuticas de accao retardada contendo como substancia veicular uma mistura de celulose microcristalina com hidroxipropil-metilcelulose
JP2001511450A (ja) チアガビンを含有する制御放出性の医薬組成物
GB2181053A (en) Controlled release formulation
KR920008817B1 (ko) 조절된 방출성(서방성) 약학적 제제의 제조방법.
HU225779B1 (en) Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
AU598751B2 (en) Pharmaceutical formulations with controlled release of the active substance
JPS62149618A (ja) 活性物質放出制御医薬製剤

Legal Events

Date Code Title Description
MKEX Expiry